June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Disruption of the homeostatic balance between TGF-β and BMPs in the outflow tissues of the CTGF-based Glaucoma mouse model
Author Affiliations & Notes
  • Sabrina Kuespert
    University Regensburg, Institut of Human Anatomy and Embryology, Regensburg, Germany
  • Ernst Tamm
    University Regensburg, Institut of Human Anatomy and Embryology, Regensburg, Germany
  • Rudolf Fuchshofer
    University Regensburg, Institut of Human Anatomy and Embryology, Regensburg, Germany
  • Footnotes
    Commercial Relationships Sabrina Kuespert, None; Ernst Tamm, None; Rudolf Fuchshofer, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4008. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sabrina Kuespert, Ernst Tamm, Rudolf Fuchshofer; Disruption of the homeostatic balance between TGF-β and BMPs in the outflow tissues of the CTGF-based Glaucoma mouse model. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4008.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To investigate the homeostatic balance between TGF-β2 and its endogenous antagonists, the bone morphogenetic proteins (BMPs), in CTGF-overexpressing mice (Junglas et al., Am J. Path. 2012) with primary open-angle glaucoma (POAG).

Methods: 2 month-old βB1-Crystallin-CTGF mice and wild-type littermates were analyzed. The amounts of BMPs, TGF-β2 and their mRNA expression, as well as that of other molecules involved in their respective signaling pathways (pSmad 1/5/8; pSmad 2/3; Smad 6/7, Gremlin) were analyzed by immunoblotting, immunohistochemistry and real-time RT-PCR. Cultured human trabecular meshwork (HTM) cells were treated under serum free conditions with different concentrations of CTGF (5 ng-100 ng) for 24 h. Changes in the expression pattern of TGF-β2 were determined by Western blot analysis and real-time RT-PCR. Blocking of the CTGF pathway was performed with an inhibitor against MEK1/2 (UO126).

Results: CTGF overexpression in βB1-Crystallin-CTGF with POAG leads to a significant decrease of BMP synthesis and signaling in aqueous humor outflow tissues when compared to wild-type littermates. In contrast, the expression of TGF-β2 and activity of its signaling were enhanced in 2-month-old transgenic mice. The examination of the inhibitory Smads showed that Smad6 was significantly enhanced in transgenic mice, whereas Smad7 was unaffected. Gremlin, a specific BMP inhibitor, was also significantly increased in CTGF overexpressing mice with POAG. In vitro, CTGF treatment led to an induction of TGF-β2 via the ERK1/2 pathway.

Conclusions: CTGF is a key modulator in the pathogenesis of POAG leading to changes in the homeostatic balance between TGF-β and BMPs. The shift towards the TGF-β pathway is initiated by an increased TGF-β expression versus a reduced BMP synthesis. In addition, an upstream blockage of BMPs by Gremlin and an enhanced downstream inhibition by Smad6 was observed in the transgenic animals. The effects appear to involve the ERK1/2 pathway. Modification of CTGF signaling seems to be a promising strategy to treat POAG.

Keywords: 543 growth factors/growth factor receptors • 568 intraocular pressure • 633 outflow: trabecular meshwork  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×